Effectiveness of an Online Psychological Support Program for Mothers of Children With Autism
Effectiveness of an Online Psychological Support Program for Mothers of Children Diagnosed With Autism Spectrum Disorder: A Controlled Study
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties in social communication and interaction, repetitive behaviors, and restricted interests. Since ASD is a developmental disorder that affects language, speech, cognitive, social, and emotional skills, raising a child with ASD can be a challenging experience for parents. Parents of children with ASD generally experience higher levels of stress, anxiety, and depression compared to parents of typically developing children, and their chronic stress levels are also higher compared to parents of children with developmental delays. A longitudinal study has shown that acceptance plays a protective role in parents' adaptation to an autism diagnosis and is associated with lower levels of depression both cross-sectionally and over time. In contrast, caregivers with increasing levels of self-blame and hopelessness toward the diagnosis have been observed to experience worsened mental health and decreased life satisfaction.
Acceptance and Commitment Therapy (ACT) is a form of cognitive-behavioral therapy that focuses on acceptance and mindfulness. This therapeutic approach aims to increase psychological flexibility by altering individuals' relationship with events and their function through six flexible hexagonal concepts (acceptance, defusion, present moment contact, context-based self, values, and value-driven behavior). A review study conducted in 2022 demonstrated that ACT interventions for parents of children with ASD can be beneficial.
The rationale for this study stems from the need for approaches to improve the mental health of mothers of children diagnosed with ASD, as these mothers experience higher levels of stress, anxiety, and depression. The literature on the effects of ACT-based interventions on parents' psychological well-being is limited. Research on the effectiveness of ACT-based psychological support programs for parents of children with ASD is still in its early stages. Therefore, it is important to evaluate how ACT-based psychological support programs affect the anxiety, stress, and depression levels of parents of children with ASD, the factors related to these effects, and how reductions in parenting stress influence children's behavioral problems and autism severity.
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Ankara, 터키 (Türkiye)
- Herguner Therapy Private Clinic
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 어린이
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- The participant must have at least one child with a clinically confirmed diagnosis of ASD.
- The child with autism must be between 2 and 11 years of age.
- Parents must be able to speak and read Turkish sufficiently.
- Parents must agree not to participate in any other mental health support program during the study.
Exclusion Criteria:
- Incomplete completion of the scales
- The child with autism is not between the ages of 2 and 11
- Parents are participating in another mental health support program.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: The intervention group
Parents in the intervention group will participate in a 5-week Online Acceptance and Commitment Therapy (ACT) Based Parent Support Program.
Six weeks after the program completion, they will attend a follow-up session for additional support.
|
The sessions are structured around the core ACT skills (contact with the present moment, acceptance, defusion, values, commitment, and contextual self).
Each session includes stages of information sharing, exemplification, meditation practice, feedback, and group discussion.
The topics and practices are derived from standardized content commonly used in ACT groups.
After each session, home exercises related to the weekly topic are provided, and feedback on these exercises is gathered from participants at the beginning of the next session.
Audio recordings for the meditation practices are created and sent to participants via email.
|
|
간섭 없음: The control group
Participants assigned to the control group will not receive the intervention during the study period.
They will remain on a waitlist and will receive the online ACT-based parent support program after completion of the post-intervention assessment.
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Changes in Depression, Anxiety, and Stress
기간: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
The Depression Anxiety Stress Scales-21 (DASS-21) is a 21-item self-report questionnaire assessing symptoms of depression, anxiety, and stress.
Each item is rated on a 4-point Likert scale (0-3).
Scores for each subscale range from 0 to 42, with higher scores indicating greater symptom severity.
The total score ranges from 0 to 126, with higher scores indicating greater overall psychological distress.
The scale will be administered at baseline (T1), at the end of the 5-week intervention (T2), and at the 6-week follow-up (T3) in the intervention group.
The control group will be assessed at T1 and T2 only.
Changes in scores from T1 to T2 will be compared between groups using analysis of covariance (ANCOVA), controlling for baseline values.
Within-group changes across T1, T2, and T3 will also be evaluated in the intervention group.
|
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Changes in Parenting Stress
기간: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
The 15-item version of the Parent Stress Scale (PSS) was used to assess parenting-related stress.
Items are rated on a 5-point Likert scale.
Total scores range from 15 to 75, with higher scores indicating greater parenting stress.
The scale was administered at baseline (T1), at the end of the 5-week intervention (T2), and at 6-week follow-up (T3) in the intervention group.
The control group was assessed at T1 and T2 only.
Changes in scores from T1 to T2 will be compared between the intervention and control groups using analysis of covariance (ANCOVA), controlling for baseline values.
Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
|
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
|
Changes in Autistic Traits (Autism Spectrum Quotient-10, AQ-10)
기간: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
The Autism Spectrum Quotient-10 (AQ-10) was used to assess autistic traits.
The scale consists of 10 items scored in a binary format (0-1).
Total scores range from 0 to 10, with higher scores indicating greater levels of autistic traits.
The scale was administered at T1, T2, and T3 in the intervention group, and at T1 and T2 in the control group.
Changes in scores from T1 to T2 will be compared between groups using ANCOVA, controlling for baseline values.
Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
|
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
|
Changes in Psychological Flexibility (Acceptance and Action Questionnaire-II, AAQ-II)
기간: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
The Acceptance and Action Questionnaire-II (AAQ-II) was used to assess psychological flexibility.
The scale consists of 7 items rated on a 7-point Likert scale.
Total scores range from 7 to 49, with higher scores indicating greater psychological inflexibility (i.e., lower psychological flexibility).
The scale was administered at T1, T2, and T3 in the intervention group, and at T1 and T2 in the control group.
Changes in scores from T1 to T2 will be compared between groups using ANCOVA, controlling for baseline values.
Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
|
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
|
Changes in Cognitive Fusion (Cognitive Fusion Questionnaire, CFQ)
기간: Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
The Cognitive Fusion Questionnaire (CFQ) was used to assess cognitive fusion.
The scale consists of 7 items rated on a 7-point Likert scale.
Total scores range from 7 to 49, with higher scores indicating greater cognitive fusion.
The scale was administered at T1, T2, and T3 in the intervention group, and at T1 and T2 in the control group.
Changes in scores from T1 to T2 will be compared between groups using ANCOVA, controlling for baseline values.
Within-group changes across T1, T2, and T3 will be evaluated for the intervention group.
|
Baseline (T1), End of Week 5 (T2), End of Week 11 (T3)
|
|
Changes in Autism Severity (Social Responsiveness Scale, SRS)
기간: Baseline (T1), End of Week 5 (T2)
|
The Social Responsiveness Scale (SRS) was used to assess autism-related social impairments in children.
The scale consists of 65 items rated on a Likert scale.
Total scores range from 0 to 195, with higher scores indicating greater severity of autism symptoms.
The scale was administered at baseline (T1) and at the end of the 5-week intervention (T2) in both groups.
Changes in scores from T1 to T2 will be compared between the intervention and control groups using ANCOVA, controlling for baseline values.
|
Baseline (T1), End of Week 5 (T2)
|
|
Changes in Behavioral Problems (Abnormal Behavior Checklist, ABC)
기간: Baseline (T1), End of Week 5 (T2)
|
The Abnormal Behavior Checklist (ABC) was used to evaluate behavioral problems in children.
The scale consists of 58 items rated on a 4-point Likert scale.
Total scores range from 0 to 174, with higher scores indicating greater severity of behavioral problems.
The scale was administered at T1 and T2 in both groups.
Changes in scores from T1 to T2 will be compared between the intervention and control groups using ANCOVA, controlling for baseline values.
|
Baseline (T1), End of Week 5 (T2)
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 연구 책임자: Sabri Hergüner, Assoc.Prof., Herguner Tharapy Private Clinic
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (실제)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- ACTParentsAutism
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .